TickerFacts.

Rani Therapeutics Holdings, Inc. (RANI): Net Income

Annual figures by period end, from SEC filings.

-$40.95M
Year ended 2025-12-31
-$33.42M
Trailing 12 months to 2026-06-30
2020-12-31: -$16.70M2021-12-31: -$53.09M2022-12-31: -$63.34M2023-12-31: -$67.88M2024-12-31: -$56.58M2025-12-31: -$40.95M-$40.95M
2020-12-31 Net Income (USD) 2025-12-31
Period endedNet IncomeChange YoYSource filing
2025-12-31-$40.95Mn/m2026-03-26, From 2025-01-01
2024-12-31-$56.58Mn/m2026-03-26, From 2024-01-01
2023-12-31-$67.88Mn/m2025-03-31, From 2023-01-01
2022-12-31-$63.34Mn/m2024-03-20, From 2022-01-01
2021-12-31-$53.09Mn/m2023-03-22, From 2021-01-01
2020-12-31-$16.70Mn/a2022-03-31, From 2020-01-01

Net Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedNet IncomeChange YoY
Rani Therapeutics Holdings, Inc. (RANI)2025-12-31-$40.95Mn/m
NRX Pharmaceuticals, Inc. (NRXP)2025-12-31-$28.62Mn/m
Bio Essence Corp (BIOE)2025-12-31$896.2Kn/m
Avenue Therapeutics, Inc. (ATXI)2025-12-31-$2.91Mn/m
Northwest Biotherapeutics Inc (NWBO)2025-12-31-$60.16Mn/m
Cannapharmarx, Inc. (CPMD)2025-12-31-$11.13Mn/m
Lipocine Inc. (LPCN)2025-12-31-$9.63Mn/m
Dianthus Therapeutics, Inc. (DNTH)2025-12-31-$162.34Mn/m
Korsana Biosciences, Inc. (KRSA)2025-12-31-$3.53Mn/m

Compare RANI, NRXP, BIOE, ATXI side by side · Screen every company in Pharmaceutical Preparations ↗